Nuevolution AB- Dansk drug discovery selskab på vej på børsen

Nuevolution AB- Dansk drug discovery selskab på vej på børsen

Nuevolution er et dansk biotech selskab som arbejder indenfor small molecules, og som qua sin unikke og meget effektive screeningprocedure kan lave tabletbaserede lægemiddelkandidater billigere. På sin patenterede Chemetics platform har man haft 15 lægemidler igennem med partnere som Merck, GSK, Novartis og Boehringer Ingelheim. Selskabet går på FirstNorth i december 2015 og er iøjeblikket på roadshow i Danmark og …

Read more.

Opportunistisk play i Danske Andelskassers Bank

Vi har idag købt 100.000 T-ret til 1 øre i DAB´s fortegningsemission, der med visse forbehold er givet fuldt tilsagn til fra de eksisterende aktionærer. Der vil efter emissionen være omkring 210 millioner aktier. Banken forventer efter emissionen og en række andre tiltag at kunne øge basisindtjeningen i 2016 til over 200 millioner kroner om året fra 125 millioner i …

Read more.

---
Atlantic Petroleum - Game over?

Atlantic Petroleum - Game over?

Atlantic Petroleum came with a dismal 3rd quarter report which disappointed due to low oil price and lower than expected production. Ben Arabo, CEO, did at a conference call a year ago state that he did not believe in an oliprice under 80 dollar for very long. He was wrong. EBITDAX for 3Q was positive with DKK 26.1MM, The X stands …

Read more.

---
2015 interview Warren Buffet

The gateway to small- and midcap stocks in Scandinavia. Steen has more than 15 years hands-on expericence in analysing and investing in stocks. He is a weekly contributor and analyst in “Aktieugebrevet”, one of the leading sources of independent analysis in Denmark.

Peter Hildebrandt, also known as “Akademikeren”, has been investing for more than 17 years. Mainly invests in Undervalued technology and biotech stocks and is currently rotating towards dividend stocks in energy and shipping.

I’m a ten year veteran of biotechnology, and currently pursuing my MBA from UCLA.  I use my knowledge of the industry and business to make my investing decisions.  I look for small to mid-cap biotech companies with innovative research and buy into their company during clinical trials.

Andreas is providing stock tips with deep fundamental research behind each stock he recommends. He is privately a portfolio manager at his own Investment company where he Invest in stocks, options, CFD’s etc. with a balanced long/short approach.

Jacob’s approach is to search for that which is undervalued and where the discount to the intrinsic value provides a large margin of safety. He believes sectors that are either out of favor or in distress typically offer the best opportunities.